Cholangiocarcinoma is a type of cancer that arises from the cells of bile ducts. It is also known as bile duct cancer and is a rare cancer that can affect both the intrahepatic (within the liver) and extrahepatic (outside the liver) bile ducts. Bile ducts are involved in the production and transport of bile, a yellowish-green substance composed of bile salts, cholesterol, and other components that help the body digest fat. Cholangiocarcinoma can be classified as either primary or secondary. Primary cholangiocarcinoma originates from the bile ducts, while secondary cholangiocarcinoma is caused by cancer that has spread to the bile ducts from other parts of the body. The risk factors for cholangiocarcinoma include chronic biliary diseases such as primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC). Other risk factors include smoking, excessive alcohol intake, and certain genetic disorders. There may also be a link between cholangiocarcinoma and certain infections or toxins.
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China